Home Cart Sign in  
Chemical Structure| 212779-48-1 Chemical Structure| 212779-48-1

Structure of NG 52
CAS No.: 212779-48-1

Chemical Structure| 212779-48-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NG 52 is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase, Cdc28p (IC50 = 7 μM), and the related Pho85p kinase (IC50 = 2 μM).

Synonyms: Compound 52

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NG 52

CAS No. :212779-48-1
Formula : C16H19ClN6O
M.W : 346.81
SMILES Code : CC(N1C=NC2=C(NC3=CC=CC(Cl)=C3)N=C(NCCO)N=C12)C
Synonyms :
Compound 52
MDL No. :MFCD02179196
InChI Key :XZEFMZCNXDQXOZ-UHFFFAOYSA-N
Pubchem ID :2856

Safety of NG 52

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of NG 52

Hedgehog

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-468 7 ng/mL 72 hours Evaluate cytotoxicity of 806-PE38 on MDA-MB-468 cells, IC50 was 7 ng/mL PMC5017938
HCC70 4 ng/mL 72 hours Evaluate cytotoxicity of 806-PE38 on HCC70 cells, IC50 was 4 ng/mL PMC5017938
BT-20 10 ng/mL 72 hours Evaluate cytotoxicity of 806-PE38 on BT-20 cells, IC50 was 10 ng/mL PMC5017938
HiPSC-derived neurons 20 μM Evaluate the inhibitory effect of adamantane series inhibitors in cells PMC7478247
Neuro-2a 30 μM Evaluate the inhibitory effect of Fmoc-D-Cys(trt)-OH on BoNT/A LC PMC7478247
WI-38 >300 ng/mL 72 hours Evaluate cytotoxicity of 806-PE38 on WI-38 cells, IC50>300 ng/mL PMC5017938
HCC1937 90 ng/mL 72 hours Evaluate cytotoxicity of 806-PE38 on HCC1937 cells, IC50 was 90 ng/mL PMC5017938
HCC1395 30 ng/mL 72 hours Evaluate cytotoxicity of 806-PE38 on HCC1395 cells, IC50 was 30 ng/mL PMC5017938
MDA-MB-231 90 ng/mL 72 hours Evaluate the toxicity of HTCG@TA on MDA-MB-231 cells, results showed only 32% cell survival PMC5017938
HER2-A775_G776YVMA-inserted lung adenocarcinoma patient-derived organoids 180 nM 72 hours Evaluate the growth inhibitory effect of pyrotinib on HER2-mutant lung cancer cells, results showed pyrotinib at plasma concentration significantly inhibited cell growth more than afatinib PMC7360147
THP-1 macrophages 5 μg/cm2 24 hours To evaluate the intracellular antibacterial activity of levofloxacin in THP-1 macrophages. Results showed that 20(S)-Rh2 significantly enhanced the bactericidal effect of levofloxacin against intracellular S. aureus in a concentration- and time-dependent manner. PMC7776606
Primary human mesothelial cells 5 μg/cm2 24 hours Assessed DNA damage repair, showing delayed H2A.X phosphorylation in BLM-silenced cells PMC7776606
Murine mesothelial cells 5 μg/cm2 8 hours Assessed genomic instability, showing significantly increased micronuclei frequency in Blm+/− cells PMC7776606
Mouse cortical neurons 30 ng/ml 2 hours To evaluate the neuroprotective effects of leptin against NMDA-induced toxicity, results showed that leptin was protective in Slo1+/+ neurons but ineffective in Slo1+/− and Slo1−/− neurons PMC4134969
Rat cortical neurons 10–100 ng/ml 2 hours To evaluate the neuroprotective effects of leptin against NMDA-induced toxicity, results showed that leptin significantly reduced NMDA-induced cell death when preincubated for 2 hours PMC4134969

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Female athymic nude mice MDA-MB-468 or HCC70 xenograft model Tail vein injection 5 μg/mouse Every other day for four times Evaluate the antitumor efficacy of 806-PE38 in MDA-MB-468 and HCC70 xenograft models, results showed that 806-PE38 significantly reduced tumor burden and prolonged survival time PMC5017938
BALB/c nude mice HER2-A775_G776YVMA-inserted lung adenocarcinoma patient-derived xenograft model Oral 5 mg/kg, 20 mg/kg, 80 mg/kg Once daily for 24 days Evaluate the antitumor effect of pyrotinib in vivo, results showed 80 mg/kg pyrotinib significantly reduced tumor volume (mean reduction of 52.2%) and was superior to afatinib and T-DM1 PMC7360147
Mouse Lethality assay Intraperitoneal injection 1 mg/kg Single dose Evaluate the protective effect of copper-ligand complexes on BoNT/A intoxicated mice PMC7478247
Mice Genetically engineered mouse models (GEMM) of small-cell lung cancer (SCLC), pancreatic ductal adenocarcinoma (PDAC), and non-small cell lung cancer (NSCLC) Blood exchange Several hours To measure the kinetics of endogenous CTCs, including their half-life in circulation and generation rate, and to assess the metastatic propensity of CTCs. Results showed that the half-life of CTCs ranged between 40 and 260 seconds, and the generation rate varied between 60 and 107,000 CTCs/hour. Additionally, direct transfer of 1-2% of CTCs generated macrometastases in healthy recipient mice. PMC8479082
Mice Blm+/− mice Intraperitoneal injection 5 mg Twice a week for 5 weeks Assessed inflammatory response and mesothelioma incidence, showing Blm+/? mice had enhanced inflammation and significantly higher mesothelioma incidence PMC7776606

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.88mL

0.58mL

0.29mL

14.42mL

2.88mL

1.44mL

28.83mL

5.77mL

2.88mL

References

 

Historical Records

Categories